Live Breaking News & Updates on Merck Sharp Dohme New Zealand Limited

Stay updated with breaking news from Merck sharp dohme new zealand limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

KEYTRUDA® (pembrolizumab) receives its 20th New Zealand registration for advanced endometrial cancer

1 April 2022, Merck Sharp & Dohme New Zealand Limited (MSD) says that KEYTRUDA has 20 indications and is now available for use in combination with lenvatinib , to treat eligible women with a type of advanced uterine cancer called endometrial carcinoma ....

New Zealand , Paul Smith , Tash Crosby , Merck Sharp Dohme New Zealand Limited , Merck Sharp , Dohme New Zealand Limited , Zealand Director , Talk Peach ,